JP2024537180A5 - - Google Patents

Info

Publication number
JP2024537180A5
JP2024537180A5 JP2024520887A JP2024520887A JP2024537180A5 JP 2024537180 A5 JP2024537180 A5 JP 2024537180A5 JP 2024520887 A JP2024520887 A JP 2024520887A JP 2024520887 A JP2024520887 A JP 2024520887A JP 2024537180 A5 JP2024537180 A5 JP 2024537180A5
Authority
JP
Japan
Prior art keywords
influenza virus
machine learning
immunogenic composition
composition according
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024520887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537180A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/045992 external-priority patent/WO2023059857A1/en
Publication of JP2024537180A publication Critical patent/JP2024537180A/ja
Publication of JP2024537180A5 publication Critical patent/JP2024537180A5/ja
Pending legal-status Critical Current

Links

JP2024520887A 2021-10-08 2022-10-07 多価インフルエンザワクチン Pending JP2024537180A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163253986P 2021-10-08 2021-10-08
US63/253,986 2021-10-08
US202163277848P 2021-11-10 2021-11-10
US63/277,848 2021-11-10
PCT/US2022/045992 WO2023059857A1 (en) 2021-10-08 2022-10-07 Multivalent influenza vaccines

Publications (2)

Publication Number Publication Date
JP2024537180A JP2024537180A (ja) 2024-10-10
JP2024537180A5 true JP2024537180A5 (enExample) 2025-10-15

Family

ID=84330622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520887A Pending JP2024537180A (ja) 2021-10-08 2022-10-07 多価インフルエンザワクチン

Country Status (10)

Country Link
US (1) US20240269258A1 (enExample)
EP (1) EP4412647A1 (enExample)
JP (1) JP2024537180A (enExample)
KR (1) KR20240076825A (enExample)
AU (1) AU2022361432A1 (enExample)
CA (1) CA3233926A1 (enExample)
IL (1) IL311964A (enExample)
MX (1) MX2024004252A (enExample)
TW (1) TW202333778A (enExample)
WO (1) WO2023059857A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024261648A1 (en) * 2023-06-19 2024-12-26 Seqirus Inc. Multivalent subtype influenza vaccine
KR20260017552A (ko) 2024-07-29 2026-02-06 한림대학교 산학협력단 바이러스 감염증의 예방 또는 치료를 위한 약학적 조성물

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
CA2281838A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US6218371B1 (en) 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
US9452209B2 (en) * 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
CN106559986A (zh) * 2014-06-20 2017-04-05 美国政府(由卫生和人类服务部的部长所代表) 多价流感病毒样颗粒(vlp)及其作为疫苗的用途
WO2019032463A1 (en) * 2017-08-07 2019-02-14 Icahn School Of Medicine At Mount Sinai IMMUNOGENIC COMPOSITIONS COMPRISING INFLUENZA VIRUS AND AS01 CHIMERIC POLYPEPTIDES OF HEMAGGLUTININ AND USES THEREOF
WO2019143955A1 (en) * 2018-01-22 2019-07-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Broadly protective inactivated influenza virus vaccine
WO2021080999A1 (en) 2019-10-21 2021-04-29 Sanofi Pasteur, Inc. Systems and methods for predicting biological responses
DK4049290T3 (da) 2019-10-21 2025-12-08 Sanofi Pasteur Inc Systemer og fremgangsmåder til design af vacciner
KR20230097028A (ko) 2020-10-28 2023-06-30 사노피 파스퇴르 Tlr4 효현제를 함유하는 리포좀, 이의 제조 및 용도

Similar Documents

Publication Publication Date Title
Kodihalli et al. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines
Epstein et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice
Zheng et al. Development of universal influenza vaccines based on influenza virus M and NP genes
AU2004263037B2 (en) Novel vaccine containing adjuvant capable of inducing mucosal immunity
Babapoor et al. A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection
Zhang et al. Advancements in the development of subunit influenza vaccines
Romanova et al. Live cold-adapted influenza A vaccine produced in Vero cell line
Kang et al. Novel vaccines against influenza viruses
US20140255343A1 (en) Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine
Chen et al. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus
CN104203272A (zh) 复合抗原序列及疫苗
US11357773B2 (en) Methods and compositions for enhancing immune response to vaccination
AU2007240128A1 (en) Influenza virus vaccine
Gambaryan et al. Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)
Sawai et al. Induction of cytotoxic T‐lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin
Rcheulishvili et al. Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs–focus on the bigger picture
WO2012060678A2 (es) Vacunas novedosas contra el virus de la influencia pandémica a/h1n1
Rimmelzwaan et al. Influenza vaccines: new developments
WO2011024748A1 (ja) インフルエンザm2由来の改変ペプチドワクチン
Horimoto et al. Designing vaccines for pandemic influenza
RU2556833C2 (ru) Аттенуированный холодоадаптированный штамм вируса гриппа а/рr/8/59/m2 (h1n1), предназначенный для получения вакцинных штаммов вируса гриппа в качестве донора аттенуации, вакцинные штаммы вируса гриппа а/59/м2/калифорния/66/2211 (н2n2) и а/59/м2/токио/67/22111 (н2n2)
JP2024540290A5 (enExample)
Wu et al. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines
Nurpeisova et al. Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine: A. Nurpeisova et al.
Topham et al. Pandemic influenza vaccines: what they have taught us about B cell immunology